Perspective: emerging challenges in the treatment of influenza and parainfluenza in transplant patients
- PMID: 22312357
- PMCID: PMC3265318
- DOI: 10.1155/2011/910930
Perspective: emerging challenges in the treatment of influenza and parainfluenza in transplant patients
Abstract
Influenza, respiratory synctial virus, and parainfluenza are common respiratory infections in immunocompromised transplant recipients, causing significant morbidity and mortality in this patient population. This paper focuses on influenza and parainfluenza virus infections in transplant patients with emphasis on the pandemic 2009 H1N1 influenza infection. Current antiviral treatment recommendations for influenza and parainfluenza in immunocompromised patients as well as novel investigational therapeutic approaches currently being tested in the clinic are discussed. In addition to the morbidity and mortality caused by these viruses, the development of multidrug resistance leading to transmission of resistant viruses is of great public health concern. The development of effective new therapies for influenza and parainfluenza in these high-risk patients is needed with randomized placebo-controlled studies to assess their clinical utility.
Similar articles
-
Long-Term Shedding of Influenza Virus, Parainfluenza Virus, Respiratory Syncytial Virus and Nosocomial Epidemiology in Patients with Hematological Disorders.PLoS One. 2016 Feb 11;11(2):e0148258. doi: 10.1371/journal.pone.0148258. eCollection 2016. PLoS One. 2016. PMID: 26866481 Free PMC article.
-
Vaccination with Recombinant Parainfluenza Virus 5 Expressing Neuraminidase Protects against Homologous and Heterologous Influenza Virus Challenge.J Virol. 2017 Nov 14;91(23):e01579-17. doi: 10.1128/JVI.01579-17. Print 2017 Dec 1. J Virol. 2017. PMID: 28931689 Free PMC article.
-
Influenza and parainfluenza respiratory viral infection requiring admission in adult lung transplant recipients.Transplantation. 2002 Apr 15;73(7):1075-8. doi: 10.1097/00007890-200204150-00010. Transplantation. 2002. PMID: 11965034
-
Viral infections in immunocompromised patients: what's new with respiratory viruses?Curr Opin Infect Dis. 2002 Aug;15(4):355-67. doi: 10.1097/00001432-200208000-00002. Curr Opin Infect Dis. 2002. PMID: 12130931 Review.
-
Community respiratory virus infections in immunocompromised patients: hematopoietic stem cell and solid organ transplant recipients, and individuals with human immunodeficiency virus infection.Semin Respir Crit Care Med. 2007 Apr;28(2):222-42. doi: 10.1055/s-2007-976494. Semin Respir Crit Care Med. 2007. PMID: 17458776 Review.
Cited by
-
Parainfluenza virus entry at the onset of infection.Adv Virus Res. 2021;111:1-29. doi: 10.1016/bs.aivir.2021.07.001. Epub 2021 Aug 23. Adv Virus Res. 2021. PMID: 34663496 Free PMC article.
-
Parainfluenza Virus Infection.Semin Respir Crit Care Med. 2016 Aug;37(4):538-54. doi: 10.1055/s-0036-1584798. Epub 2016 Aug 3. Semin Respir Crit Care Med. 2016. PMID: 27486735 Free PMC article. Review.
-
Respiratory viral infections post-lung transplantation.Curr Respir Care Rep. 2012;1(3):162-167. doi: 10.1007/s13665-012-0017-x. Epub 2012 Jun 20. Curr Respir Care Rep. 2012. PMID: 32226645 Free PMC article. Review.
-
Current management of parainfluenza pneumonitis in immunocompromised patients: a review.Infect Drug Resist. 2012;5:121-7. doi: 10.2147/IDR.S25874. Epub 2012 Aug 8. Infect Drug Resist. 2012. PMID: 22893749 Free PMC article.
References
-
- Leung TWC, Tai ALS, Cheng PKC, Kong MSY, Lim W. Detection of an oseltamivir-resistant pandemic influenza A/H1N1 virus in Hong Kong. Journal of Clinical Virology. 2009;46(3):298–299. - PubMed
-
- Oseltamivir resistant 2009 pandemic influenza A(H1N1) virus infection in two summer campers receiving prophylaxis- North Carolina, 2009. Morbidity and Mortality Weekly Report. 2009;58(35):969–972. - PubMed
-
- Ito T. Interspecies transmission and receptor recognition of influenza A viruses. Microbiology and Immunology. 2000;44(6):423–430. - PubMed
LinkOut - more resources
Full Text Sources